Literature DB >> 991434

Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth.

P D Gluckman, I M Holdaway.   

Abstract

Three children with hypothalamic mass lesions and continued linear growth in the absence of circulating growth hormone are presented. Serum growth hormone levels were either undetectable or very low both basally and following insulin-induced hypoglycaemia, whereas serum somatomedin levels were normal. Two subjects had elevated serum levels of prolactin, and in one of these prolactin suppression with bromoergocryptine failed to influence either somatomedin levels or urinary excretion of nitrogen, hydroxyproline and calcium. Although only one case was studied in detail these data suggest that maintenance of serum somatomedin and of normal growth in these children was not dependent upon prolactin secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991434     DOI: 10.1111/j.1365-2265.1976.tb01984.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

Authors:  F Minuto; A Barreca; P Del Monte; P Fortini; M Resentini; F Morabito; G Giordano
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

2.  Isolated ACTH deficiency confirmed by ACTH radioimmunoassay.

Authors:  T C Ooi; I M Holdaway; R A Donald; H K Ibbertson
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

3.  Long-term follow-up of children with craniopharyngioma.

Authors:  N Stahnke; G Grubel; I Lagenstein; R P Willig
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

4.  Pre- and postoperative evaluation of hypothalamo- pituitary function in children with craniopharyngiomas.

Authors:  W Andler; K Roosen; H E Clar
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.